(Total Views: 332)
Posted On: 09/03/2019 1:53:24 PM
Post# of 156420
For THERF that was a 100% increase in share price. I think the superiority of our drug will give us 220% and I'm being a bit conservative with that price.
With the current blaise attitude toward our stock I think it will take increasing script numbers and revenue for our share price to start reflecting it's actual worth. By September 2020 I would expect $5.00 per share. What will really drive this stock price is full Phase 2 mTNBC trial results and interim mono results.
Very long term, on any metastatic cancer approval I would expect $75-$80 a share.
With the current blaise attitude toward our stock I think it will take increasing script numbers and revenue for our share price to start reflecting it's actual worth. By September 2020 I would expect $5.00 per share. What will really drive this stock price is full Phase 2 mTNBC trial results and interim mono results.
Very long term, on any metastatic cancer approval I would expect $75-$80 a share.
(1)
(0)
